Femasys Inc. announced that Fred Aslan, Founder and Chief Executive Officer of Advance Medical Inc. and Vice President of Venrock and Charles E. Larsen, Managing Director of Accuitive Medical Ventures, have been appointed to the Femasys Board of Directors. Both new directors bring significant leadership, operations and commercial experience to Femasys as the Company prepares to commence its pivotal trial of FemBloc™ which is designed to provide women with the first non-surgical permanent contraception option delivered exclusively in the office. Dr. Aslan is currently the Founder and Chief Executive Officer of Advance Medical and he is also a Vice President at Venrock.

Mr. Larsen has over 35 years of operating and technical experience in the medical device industry. He co-founded Novoste Corporation and The Innovation Factory and through his role at The Innovation Factory, he co-founded additional companies including: Acufocus, AqueSys, Halscion, LipoSonix, Neuronetics and Sebacia.